Victoria Vilalta (@victoria_vilata) 's Twitter Profile
Victoria Vilalta

@victoria_vilata

Interventional Cardiologist. MSc. PhD 🫀

ID: 796036601935724544

calendar_today08-11-2016 17:08:10

710 Tweet

1,1K Takipçi

444 Takip Edilen

L'Institut del Cor del Germans Trias (@icorgtrias) 's Twitter Profile Photo

𝐅𝐫𝐨𝐦 𝐭𝐡𝐞 𝐢𝐂𝐨𝐫 𝐆𝐞𝐫𝐦𝐚𝐧𝐬 𝐓𝐫𝐢𝐚𝐬 𝐤𝐧𝐨𝐰𝐥𝐞𝐝𝐠𝐞 𝐚𝐧𝐝 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐭𝐨 𝐓𝐡𝐞 𝐀𝐦𝐞𝐫𝐢𝐜𝐚𝐧 𝐂𝐨𝐥𝐥𝐞𝐠𝐞 𝐨𝐟 𝐂𝐚𝐫𝐝𝐢𝐨𝐥𝐨𝐠𝐲 𝐂𝐨𝐧𝐠𝐫𝐞𝐬𝐬 𝟐𝟎𝟐𝟓🫀 🔗 linkedin.com/posts/icor-ger… #iCorGermansTrias #HGermansTrias #Cardiology #ACC25

𝐅𝐫𝐨𝐦 𝐭𝐡𝐞 𝐢𝐂𝐨𝐫 𝐆𝐞𝐫𝐦𝐚𝐧𝐬 𝐓𝐫𝐢𝐚𝐬 𝐤𝐧𝐨𝐰𝐥𝐞𝐝𝐠𝐞 𝐚𝐧𝐝 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐭𝐨 𝐓𝐡𝐞 𝐀𝐦𝐞𝐫𝐢𝐜𝐚𝐧 𝐂𝐨𝐥𝐥𝐞𝐠𝐞 𝐨𝐟 𝐂𝐚𝐫𝐝𝐢𝐨𝐥𝐨𝐠𝐲 𝐂𝐨𝐧𝐠𝐫𝐞𝐬𝐬 𝟐𝟎𝟐𝟓🫀

🔗 linkedin.com/posts/icor-ger…

#iCorGermansTrias #HGermansTrias #Cardiology #ACC25
JACC Journals (@jaccjournals) 's Twitter Profile Photo

📢 New in #JACCINT: In the #SwissTAVI Registry, patients needing pacemaker implantation within 30 days after #TAVR faced higher all-cause death and CV mortality up to 10 years. Long-term risks remain significant! 📊 jacc.org/doi/10.1016/j.… Patrick Badertscher

📢 New in #JACCINT: In the #SwissTAVI Registry, patients needing pacemaker implantation within 30 days after #TAVR faced higher all-cause death and CV mortality up to 10 years. Long-term risks remain significant! 📊 jacc.org/doi/10.1016/j.… <a href="/BadertscherPat/">Patrick Badertscher</a>
Davide Capodanno (@dfcapodanno) 's Twitter Profile Photo

The European Valve Durability TAVI Registry highlights the long-term performance of TAVI. The incidence of moderate or severe structural valve deterioration (SVD) during long-term follow-up was relatively low, with severe SVD being even rarer than moderate SVD. SVD occurred more

The European Valve Durability TAVI Registry highlights the long-term performance of TAVI. The incidence of moderate or severe structural valve deterioration (SVD) during long-term follow-up was relatively low, with severe SVD being even rarer than moderate SVD. SVD occurred more
ACI-SEC: Hemodinamica (@shci_sec) 's Twitter Profile Photo

🫀 #ACISEC2025 - Arrancan las sesiones teórico-prácticas simultáneas de 1 hora: 📍 Accesos vasculares 📍 Diagnóstico intracoronario 📍 ACTP compleja 👥 Con expert@s de hospitales de toda España

Belén Cid Alvarez (@belcid7) 's Twitter Profile Photo

Espectacular sesión sobre intervencionismo mitral y tricúspide moderado por Manuel Pan y Victoria Delgado con panelistas de lujo Luisa Salido MD, PhD Fernando Sarnago Ceb Isaac Pascual Ramón Calviño y Juan Alonso: -Caso de intervencionismo combinado mitral y tricúspide desde H Álvaro Cunqueiro

L'Institut del Cor del Germans Trias (@icorgtrias) 's Twitter Profile Photo

𝐍𝐨𝐭𝐚𝐛𝐥𝐞 𝐫𝐞𝐩𝐫𝐞𝐬𝐞𝐧𝐭𝐚𝐜𝐢𝐨́ 𝐝𝐞 𝐥’𝐢𝐂𝐨𝐫 𝐚𝐥 𝟑𝟕𝐞̀ 𝐂𝐨𝐧𝐠𝐫𝐞́𝐬 𝐝𝐞 𝐥𝐚 𝐒𝐨𝐜𝐢𝐞𝐭𝐚𝐭 𝐂𝐚𝐭𝐚𝐥𝐚𝐧𝐚 𝐝𝐞 𝐂𝐚𝐫𝐝𝐢𝐨𝐥𝐨𝐠𝐢𝐚🫀 L’Institut del Cor de l’Hosp. Germans Trias, present al #CatCardioCongres37. (1/2) #HGermansTrias #Cardiologia

𝐍𝐨𝐭𝐚𝐛𝐥𝐞 𝐫𝐞𝐩𝐫𝐞𝐬𝐞𝐧𝐭𝐚𝐜𝐢𝐨́ 𝐝𝐞 𝐥’𝐢𝐂𝐨𝐫 𝐚𝐥 𝟑𝟕𝐞̀ 𝐂𝐨𝐧𝐠𝐫𝐞́𝐬 𝐝𝐞 𝐥𝐚 𝐒𝐨𝐜𝐢𝐞𝐭𝐚𝐭 𝐂𝐚𝐭𝐚𝐥𝐚𝐧𝐚 𝐝𝐞 𝐂𝐚𝐫𝐝𝐢𝐨𝐥𝐨𝐠𝐢𝐚🫀

L’Institut del Cor de l’<a href="/hgermanstrias/">Hosp. Germans Trias</a>, present al #CatCardioCongres37.

(1/2)

#HGermansTrias #Cardiologia
Victoria Delgado (@vdelgadogarcia) 's Twitter Profile Photo

With all the discussions around asymptomatic severe AS and treatment options, this trial will help to further define the indications for early AVR. Very happy to participate in the EASY-AS with Elena Ferrer Sistach and Laia Cortés ValvulopatiasSEC SFC - Valvulopathies Victoria Vilalta

Omar M. Abdelfattah, MD, FESC (@abdelfattahmd) 's Twitter Profile Photo

🚨🫀Our latest paper in JACC Journals CR shows ASA & Mavacamten effectively relieve obstruction in patients with severe AS and oHCM. Check out our stepwise treatment algorithm in High 🗡️ Risk Case Series with concomitant oHCM & AS spearheaded by Matthew W Martinez Robyn Bryde, MD

🚨🫀Our latest paper in <a href="/JACCJournals/">JACC Journals</a> CR shows ASA &amp; Mavacamten effectively relieve obstruction in patients with severe AS and oHCM. Check out our stepwise treatment algorithm in High 🗡️ Risk Case Series with concomitant oHCM &amp; AS spearheaded by <a href="/mmartinezheart/">Matthew W Martinez</a> <a href="/RobynBrydeMD/">Robyn Bryde, MD</a>